Loading…
Arlington Cemetery Marker Fairness Act
Legislative Progress
Introduced
February 18, 2022
Latest Action
March 28, 2022
Primary Sponsor
Cathy McMorris RodgersRepublican(WA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
72pct
38d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Arlington Cemetery Marker Fairness Act This bill requires that headstones other than standard white uniform military grave markers be permitted in certain sections of Arlington National Cemetery. The bill places limits on certain aspects of the headstones, including limitations on size.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2024 · second_quarter · Medicare/Medicaid
Support for H.R.5539 - Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
Client expense: Not reported · Firm income: $60,000
Referred to the Subcommittee on Disability Assistance and Memorial Affairs.
Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medicare/Medicaid
Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Medicare/Medicaid
Legislation impacting products approved under the Accelerated Approval pathway. Legislation regarding implementation of the Food and Drug Omnibus Reform Act of 2022. Legislation to improve education and care pathways for patients with rare kidney disease. H.R.6790, New Era of Preventing End-Stage Kidney Disease Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE